Targeting RIPK1 to modulate cell death and tumour microenvironment in cancer therapy
{{output}}
Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) is crucial in regulating inflammation, apoptosis, and necroptosis. Accumulating evidence highlights RIPK1 as a promising therapeutic target for various human diseases, including neurodegenerative d... ...
